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General procedures: All reactions were carried out in flame-dried glassware under Ar. 
All the solvents were purified by distillation over the drying agents indicated and were 
transferred under Ar. CH2Cl2 (CaH2), hexane and toluene (Na/K). Flash 
chromatography: Merck silica gel 60 (230-400 mesh). IR: Nicolet FT-7199 spectrometer, 
wavenumbers in cm−1. MS (EI): Finnigan MAT 8200 (70 eV), ESI-MS: Finnigan MAT 95, 
accurate mass determinations: Bruker APEX III FT-MS (7 T magnet). NMR: Spectra 
were recorded on a Bruker DPX 300 or AV 400 spectrometer in the solvents indicated; 
1H and 13C chemical shifts (δ) are given in ppm relative to TMS, coupling constants (J) in 
Hz. The solvent signals were used as references and the chemical shifts converted to 
the TMS scale. All commercially available compounds (Acros, Fluka, Lancaster, Alfa 
Aesar, Aldrich) were used as received unless stated otherwise. 
 
General procedure for the synthesis of tris(fluorophenyl)boranes: 
 
The corresponding di- or trifluoro-substituted bromobenzene (3 eq.) was dissolved in 
freshly distilled THF (0.05 M) and cooled to -20 °C. At this temperature i-PrMgCl (3 eq., 
2.0 M in Et2O) was added dropwise. The reaction mixture was then allowed to reach 
0 °C and after 1 h at this temperature cooled again to -50 °C. Subsequently, BF3•Et2O (1 
eq.) was added dropwise and after 1 h the cooling bath was removed and the reaction 
mixture warmed to room temperature within another hour. Removal of all volatiles and 
sublimation of the remaining solid (120 °C, 1•10-3 mbar) afforded the desired boranes as 
white solids. 
 
Compound 4: Prepared following the general procedure from 1-bromo-2,4,6-
trifluorobenzene (0.57 mL, 4.8 mmol), i-PrMgCl (2.0 M in Et2O, 
2.4 mL, 4.8 mmol) and BF3•Et2O (0.20 mL, 1.6 mmol). White solid 
(550 mg, 85%). 
 1H NMR (300 MHz, CD2Cl2) δ = 6.68 (dd, J = 8.9, 8.0 Hz, 6H) 
ppm. 
13C NMR (75 MHz, CD2Cl2) δ = 100.8 (ddd, J = 30.2, 25.0, 3.2 Hz), 166.5 (dt, J = 252.2, 
14.9 Hz), 167.1 (dt, J = 255.1, 16.8 Hz) ppm.  
11B NMR (96 MHz, CD2Cl2) δ = 59.4 ppm.  











IR (neat) v~  = 720, 838, 875, 891, 998, 1022, 1113, 1164, 1224, 1291, 1326, 1412, 1424, 
1479, 1518, 1579, 1602, 1629, 3112 cm-1. 
HRMS calcd. for C18H6BF9: 404.041883; found: 404.041906. 
 
Compound 5: Prepared following the general procedure from 1-bromo-2,4,5-
trifluorobenzene (0.50 mL, 4.2 mmol), i-PrMgCl (2.0 M in Et2O, 
2.1 mL, 4.2 mmol) and BF3•Et2O (0.18 mL, 1.4 mmol). White solid 
(425 mg, 75%). 
1H NMR (300 MHz, CD2Cl2) δ = 6.97-7.05 (m, 3H), 7.16 (dt, J = 
9.8, 5.5 Hz, 3H) ppm.  
13C NMR (75 MHz, CD2Cl2) δ = 106.3 (dd, J = 31.6, 20.3 Hz), 
125.5 (ddd, J = 17.6, 9.0, 2.1 Hz), 147.4 (ddd, J = 246.0, 12.1, 3.4 Hz), 154.1 (dt, J = 
257.9, 14.1 Hz), 162.6 (ddd, J = 250.7, 9.7, 2.1 Hz) ppm.  
11B NMR (96 MHz, CD2Cl2) δ = 61.8 ppm. 
19F NMR (282 MHz, CD2Cl2) δ = -143.9 (dd, J = 22.1, 15.7 Hz, 3F), -126.0 (dd, J = 22.1, 
8.8 Hz, 3F), -100.4 (dd, J = 15.8, 8.6 Hz, 3F) ppm.  
IR (neat) v~  = 681, 719, 746, 778, 815, 893, 1040, 1085, 1128, 1140, 1183, 1193, 1276, 
1298, 1393, 1419, 1491, 1618, 3080, 3476, 3547 cm-1.  
HRMS calcd. for C18H6BF9: 404.041883; found: 404.041715. 
 
Compound 6: Prepared following the general procedure from 1-bromo-2,6-
difluorobenzene (1.0 mL, 8.8 mmol), i-PrMgCl (2.0 M in Et2O, 4.4 mL, 
8.8 mmol) and BF3•Et2O (0.37 mL, 2.9 mmol). White solid (609 mg, 
59%). 
1H NMR (300 MHz, CD2Cl2) δ = 6.91 (t, J = 8.2 Hz, 6H), 7.46-7.56 (m, 
3H) ppm. 
13C NMR (75 MHz, CD2Cl2) δ = 111.6 (dd, J = 26.5, 1.7 Hz), 135.5 (t, J = 11.6 Hz), 165.5 
(dd, J = 250.5, 11.9 Hz) ppm. 
11B NMR (96 MHz, CD2Cl2) δ = 63.6 ppm. 
19F NMR (282 MHz, CD2Cl2) δ = -99.8 ppm. 
IR (neat) v~  = 699, 732, 780, 871, 966, 1120, 1169, 1211, 1239, 1283, 1316, 1439, 1558, 
1614, 3503 cm-1. 
















Compound 7: Prepared following the general procedure from 1-bromo-2,4-
difluorobenzene (1.0 mL, 8.8 mmol), i-PrMgCl (2.0 M in Et2O, 
4.4 mL, 8.8 mmol) and BF3•Et2O (0.37 mL, 2.9 mmol). White solid 
(408 mg, 41%). 
1H NMR (300 MHz, CD2Cl2) δ = 6.86 (dt, J = 9.5, 2.3 Hz, 3H), 6.97 
(dt, J = 8.3, 2.4 Hz, 3H), 7.36 (q, J = 7.8 Hz, 3H) ppm. 
13C NMR (75 MHz, CD2Cl2) δ = 104.1 (dd, J = 29.2, 24.5 Hz), 111.7 (dd, J = 20.4, 3.3 
Hz), 140.4 (t, J = 9.8 Hz), 165.6 (dd, J = 74.2, 12.7 Hz), 169.0 (dd, J = 72.5, 12.6 Hz) 
ppm. 
11B NMR (96 MHz, CD2Cl2) δ = 63.0 ppm. 
19F NMR (282 MHz, CD2Cl2) δ = -104.1 (d, J = 11 Hz, 3F), -95.7 (d, J = 11 Hz, 3F) ppm. 
IR (neat) v~  = 674, 712, 732, 742, 815, 849, 968, 1081, 1090, 1113, 1136, 1227, 1248, 
1289, 1402, 1495, 1575, 1596, 3075 cm-1. 
HRMS calcd. for C18H9BF6: 350.070154; found: 350.070459. 
 
Alkylidene disulfones,1 sulfonoesters2 and nitroalkenes3 were prepared accordingly to 
the procedures described in the literature. The spectroscopic and analytic 
characterization of those not reported follows: 
 
Compound 19: 1H NMR (300 MHz, CDCl3) δ = 1.11 (t, J = 7.1 Hz, 3H), 4.19 (q, J = 7.1 
Hz, 2H), 7.55 (t, J = 7.8 Hz, 4H), 7.60-7.68 (m, 3H), 7.96 (d, J = 
7.5 Hz, 2H), 8.01 (s, 1H) ppm. 
13C NMR (75 MHz, CDCl3) δ = 13.6, 62.9, 123.6 (q, J = 268.6 
Hz), 125.5, 125.8 (q, J = 3.8 Hz), 128.7, 129.2, 129.9, 132.7 (q, 
J = 32.8 Hz), 134.0, 135.3, 135.3, 137.8, 139.6, 142.0, 162.5 ppm. 
19F NMR (282 MHz, CDCl3) δ = -63.1 ppm. 
IR (neat) v~  = 685, 730, 830, 909, 1016, 1067, 1086, 1115, 1151, 1217, 1320, 1373, 
1448, 1623, 1724, 2988 cm-1. 
HRMS calcd. for C18H15F3O4S: 407.053534; found: 407.053511. 
 
 
                                                 
1 a) S. Sulzer-Mossé, A. Alexakis, J. Mareda, G. Bollot, G. Bernardinelli, Y. Filinchuk, Chem. Eur. J. 2009, 15, 3204-
3220; b) H. Asahara, H. Mayr, Chem. Asian J. 2012, 7, 1401-1407 
2 D. A. R. Happer, B. E. Steenson, Synthesis, 1980, 806-807. 
3 a) P. J. Black, G. Cami-Kobeci, M. G. Edwards, P. A. Slatford, M. K. Whittlesey, J. M. J. Williams, Org. Biomol. 

















Compound 22: 1H NMR (400 MHz, CD2Cl2) δ = 7.32-7.39 (m, 2H), 7.42-7.54 (m, 4H), 
7.54-7.60 (m, 1H), 7.69 (dd, J = 16.4, 8.3 Hz, 4H), 7.77-7.84 (m, 
1H), 8.10 (dd, J = 8.4, 1.2 Hz, 2H), 8.73 (s, 1H) ppm. 
13C NMR (101 MHz, CD2Cl2) δ = 124.6 (q, J = 263.0 Hz), 125.6 (q, J 
= 3.7 Hz), 128.5, 129.4, 129.6, 129.8, 130.0, 134.8, 134.9, 135.1, 
132.6 (q, J = 31.6 Hz), 139.9, 140.5, 147.8, 150.7 ppm. 
19F NMR (376 MHz, CD2Cl2) δ = -63.3 ppm. 
IR (neat) v~ = 658, 683, 719, 739, 753, 832, 945, 999, 1018, 1065, 1081, 1110, 1124, 
1149, 1319, 1408, 1448, 1479, 1595, 3007, 3071 cm-1. 
HRMS calcd. for C21H15F3O4S2Na: 475.025608; found: 475.025730.  
 
Reduction products: All nitroalkanes obtained after reduction of the corresponding 
nitroolefines were known products.4 
 
Compound 26: After hydrogenation following the general procedure it was purified by 
flash chromatography (SiO2; hexanes : ethyl acetate, 6:1) to afford a 
colourless oil (64 mg, 97%).  
1H NMR (400 MHz, CDCl3) δ = 0.99 (t, J = 7.1 Hz, 3H), 3.23 (dd, J = 
16.5, 9.0 Hz, 1H), 3.42 (dd, J = 13.6, 3.4 Hz, 1H), 3.97 (qd, J = 7.1, 
2.8 Hz, 2H), 4.20 (dd, J = 11.9, 3.5 Hz, 1H), 7.09-7.16 (m, 2H), 7.18-7.31 (m, 4H), 7.55-
7.64 (m, 2H), 7.66-7.76 (m, 1H), 7.90-7.99 (m, 2H) ppm.  
13C NMR (101 MHz, CDCl3) δ = 12.8, 31.7, 61.3, 71.3, 126.4, 127.9, 128.0, 128.3, 128.5, 
133.5, 134.7, 136.33, 164.41 ppm.  
IR (neat) v~  = 699, 722, 749, 800, 849, 1024, 1083, 1144, 1196, 1228, 1260, 1322, 1369, 
1447, 1369, 1447, 1495, 1585, 1603, 1736, 2936, 2983, 3027, 3063 cm-1. 
HRMS calcd. for C17H18O4SNa: 341.081805; found: 341.081546.  
 
Compound 27: After hydrogenation following the general procedure it was purified by 
flash chromatography (SiO2; hexanes : ethyl acetate, 6:1) to 
afford a colourless oil (57 mg, 97%).  
1H NMR (300 Mz, CDCl3 ) δ = 1.00 (t, J = 7.1 Hz, 3H), 3.25-3.39 
(m, 1H), 3.49 (dd, J = 13.7, 3.5 Hz, 1H), 3.98 (q, J = 6.1 Hz, 2H), 
                                                 



















4.20 (dd, J = 11.6, 3.7 Hz, 1H), 7.28 (d, J = 8.3 Hz, 2H), 7.48-7.67 (m, 4H), 7.73 (t, J = 
7.4 Hz, 1H), 7.89-8.01 (m, 2H) ppm. 
13C NMR (75 MHz, CDCl3) δ = 13.8, 32.4, 62.5, 71.9, 125.9 (q, J = 3.7 Hz), 129.3, 129.5, 
129.6, 129.9 (q, J = 33.4 Hz), 134.6, 137.3, 140.0, 165.1 ppm. (CF3 signal not observed). 
19F NMR (282 MHz, CDCl3) δ = -62.9 ppm.  
IR (neat) v~ = 687, 721, 737, 758, 825, 852, 876, 1018, 1066, 1083, 1109, 1121, 1145, 
1194, 1231, 1260, 1321, 1370, 1419, 1448, 1585, 1618, 1735, 2986, 3070 cm-1. 
HRMS calcd. for C18H17F3O4SNa: 409.069186; found: 409. 068888.  
 
Compound 28: After hydrogenation following the general procedure it was purified by 
flash chromatography (SiO2; hexanes : ethyl acetate, 6:1) to 
afford a colourless oil (48 mg, 65%).  
1H NMR (400 MHz, CDCl3) δ = 0.99 (t, J = 7.1 Hz, 3H), 3.17 (dd, 
J = 13.6, 12.0 Hz, 1H), 3.35 (dd, J = 13.7, 3.5 Hz, 1H), 3.96 (q, 
J = 7.1 Hz, 2H), 3.75 (s, 3H), 4.15 (dd, J = 11.9, 3.5 Hz, 1H), 6.72-6.84 (m, 2H), 7.00-
7.09 (m, 2H), 7.53-7.64 (m, 2H), 7.64-7.75 (m, 1H), 7.86-7.98 (m, 2H) ppm. 
13C NMR (101 MHz, CDCl3) δ = 13.8, 31.9, 55.3, 62.2, 72.5, 114.3, 127.5, 129.2, 129.5, 
130.0, 134.4, 137.3, 158.9, 165.43 ppm. 
IR (neat) v~  = 688, 722, 735, 753, 822, 852, 874, 1031, 1083, 1110, 1144, 1178, 1196, 
1248, 1310, 1321, 1369, 1391, 1447, 1465, 1512, 1584, 1612, 1734, 2383, 2937, 2984, 
3067 cm-1. 
HRMS calcd. for C18H20O5S: 371.092363; found: 371.092279.  
 
Compound 29: After hydrogenation following the general procedure it was purified by 
flash chromatography (SiO2; hexanes : ethyl acetate, 2:1) to afford a 
crystalline white solid (74.5 mg, 98%). 
 1H NMR (400 MHz, CD2Cl2) δ = 3.51 (d, J = 5.8 Hz, 2H), 4.78 (t, J = 5.8 
Hz, 1H), 6.98-7.00 (m, 2H), 7.16-7.20 (m, 3H), 7.51-7.55 (m, 4H), 7.66-
7.71 (m, 2H), 7.81-7.84 (m, 4H) ppm. 
13C NMR (101 MHz, CD2Cl2) δ = 31.6, 85.2, 127.5, 129.0, 129.6, 129.7, 135.0, 136.6, 
138.6 ppm. 
IR (neat) v~  = 685, 697, 710, 727, 737, 755, 764, 777, 806, 838, 854, 899, 928, 997, 
1006, 1022, 1077, 1141, 1152, 1178, 1205, 1265, 1306, 1318, 1327, 1345, 1446, 1455, 











HRMS calcd. for C20H18O4S2Na: 409.053872; found: 409.054162. 
 
Compound 30: After hydrogenation following the general procedure it was purified by 
flash chromatography (SiO2; hexanes : ethyl acetate, 2:1) 
(88 mg, 95%). 
1H NMR (300 MHz, CDCl3) δ = 3.60 (d, J = 5.5 Hz, 2H), 4.72 (t, J = 
5.6 Hz, 1H), 7.18 (d, J = 7.9 Hz, 2H), 7.48 (d, J = 11.6 Hz, 2H), 7.53 
(d, J = 7.7 Hz 4H), 7.66 (d, J = 7.4 Hz, 2H), 7.85 (d, J = 7.7 Hz, 4H) 
ppm.  
13C NMR (75 MHz, CDCl3) δ = 31.3, 85.0, 124.1 (J = 262.2 Hz), 125.8 (q, J = 3.8 Hz), 
129.3, 129.4, 129.6, 129.8 (q, J = 36.6 Hz), 134.9, 138.1, 140.5 ppm.  
19F NMR (282 MHz, CDCl3) δ = -62,7 ppm.  
IR (neat) v~  = 686, 736, 758, 787, 823, 853, 911, 999, 1019, 1067, 1078, 1122, 1155, 
1260, 1323, 1420, 1448, 1584, 1619, 1708, 2931, 3071 cm-1.  
HRMS calcd. for C21H17F3O4S2Na: 477.041262; found: 477.041384  
 
Compound 31: After hydrogenation following the general procedure it was purified by 
flash chromatography (SiO2; hexanes : ethyl acetate, 2:1) 
(82 mg, 96%). 
1H NMR (400 MHz, CDCl3) δ = 3.48 (d, J = 5.5 Hz, 2H), 3.76 (s, 
3H), 4.69 (t, J = 5.5 Hz, 1H), 6.71 (d, J = 8.7 Hz, 2H), 6.94 (d, J = 
8.6 Hz, 2H), 7.52 (t, J = 7.8 Hz, 4H), 7.66 (t, J = 7.5 Hz, 2H), 7.86 
(dd, J = 8.3, 1.0 Hz, 4H) ppm.  
13C NMR (101 MHz, CDCl3) δ = 30.7, 55.4, 85.6, 114.2, 128.3, 129.2, 129.6, 129.9, 
134.6, 138.4, 158.8 ppm.  
IR (neat) v~ = 724, 756, 793, 821, 850, 907, 998, 1032, 1078, 1109, 1148, 1178, 1247, 
1311, 1325, 1447, 1478, 1513, 1584, 1612, 2257, 2837, 2963, 3007, 3067 cm-1. 
HRMS calcd. for C21H20O5S2Na: 439.064436; found: 439.064528.  
 
Compound 38: After hydrogenation following the general procedure it was purified by 
flash chromatography (SiO2; hexanes : ethyl acetate, 6:1) to afford a 
colourless oil (35.5 mg, 95%).  
1H NMR (400 MHz, CDCl3) δ = 3.31 (t, J = 7.3 Hz, 2H), 4.63 (t, J = 7.3 Hz, 2H), 7.01-
7.65 (m, 5H) ppm. 















IR (neat) v~  = 697, 750, 862, 907, 1030, 1083, 1183, 1223, 1377, 1431, 1455, 1496, 
1547, 2923, 3031 cm-1. 
















































Deuterium labelling experiments: 
 
Synthesis of [tBu3PH][DB(2,4,6-F-Ph)3]: A solution of tBu3P (0.45 ml, 0.9 mmol, 2.0 M 
in toluene) was added to a stirring solution of 360 
mg (0.9 mmol) of tris(2,4,6-trifluorophenyl)borane in 
9.1 ml of toluene (0.1 M). Bubbling of D2 to the 
clear solution immediately forms a white precipitate. 
The volume of the resulting suspension was then 
reduced to the half and 6 ml of n-pentane are 
added. After removing of the solvent by filtration, the residue is washed twice with 6 ml 
n-pentane and further purified by column chromatography affording (SiO2; CH2Cl2) 155 
mg (30%) of [tBu3PH][DB(2,4,6-F-Ph)3] as a white solid. 
1H NMR (300 MHz, CD3CN) δ = 1.60 (d, J = 15.5 Hz, 27H), 5.40 (d, J = 443.7 Hz, 1H), 
6.39 (dd, J = 9.5, 7.1 Hz, 6H) ppm. 
13C NMR (75 MHz, CD3CN) δ = 30.3, 98.5 (dd, J = 36.6, 37.3 Hz), carbon atoms directly 
attached to F were not observed. 
11B NMR (96 MHz, CD2Cl2) δ = -25.6 ppm. 
19F NMR (282 MHz, CD2Cl2) δ = -119.9, -99.8 ppm. 
31P NMR (122 MHz, CD2Cl2) δ = 57.1 ppm. 
IR (neat) v~  = 674, 739, 809, 890, 934, 942, 994, 1031, 1101, 1156, 1177, 1206, 1281, 
1309, 1321, 1380, 1401, 1436, 1463, 1473, 1484, 1514, 1582, 1617, 1689, 1764, 2922, 
2980, 3004, 3085 cm-1. 
ESI MS(pos.) [tBu3PH]+ = 203 m/z. 
ESI MS(neg.) [DB(2,4,6-F-Ph)3]- = 406 m/z. 
HRMS calcd. for C18H6DBF9: 406.056535; found: 406.056621. 
 
Synthesis of K[DB(2,4,6-F-Ph)3]: A solution of [tBu3PH][DB(2,4,6-F-Ph)3] (188 mg, 0.31 
mmol) in THF (10 mL) was treated with KH (19 mg, 0.47 
mmol) and the resulting suspension stirred for 1 hour at r.t. 
Filtration afforded a transparent solution that was 
evaporated in vacuum. The white precipitate thus obtained 
was washed with pentane (4 x 4 mL) and dried in vacuum 
affording the desired salt (110 mg, 80%).  
1H NMR (300 MHz, CD3CN) δ = 6.40 (dd, J = 9.6, 7.2 Hz, 6H) ppm. 























19F NMR (282 MHz, CD2Cl2) δ = -120.6, -100.2 (t, J = 3.4 Hz) ppm. 
 
Synthesis of [HDABCO][DB(2,4,6-F-Ph)3]: A solution of 35 mg DABCO•HCl in 
acetonitrile (5.0 ml) was added dropwise under argon to a 
stirring solution of K[DB(2,4,6-F-Ph)3] (100 mg, 0.23 
mmol) in acetonitrile (2.3 ml, 0.1 M) and stirred over night. 
The resulting suspension was filtered off, the filtrate 
evaporated and the residue washed three times with n-
pentane (5 ml). The white solid thus obtained was dried 
under high vacuum affording 88 mg (74%) of [HDABCO][DB(2,4,6-F-Ph)3]. 1H NMR 
(300 MHz, CD3CN) δ = 3.05 (s, 12H), 6.41 (dd, J = 9.5, 7.1 Hz, 6H), 7.37 (br s, 1H) ppm; 
13C NMR (75 MHz, CD3CN) δ = 45.5, 98.5 (dd, J = 37.0, 36.3 Hz), 161.1 (dt, J = 238.2 
Hz, 17.1 Hz), 167.4 (dm, J = 239.1 Hz); 1B NMR (96 MHz, CD3CN) δ = -26.0 ppm; 19F 
NMR (282 MHz, CD3CN) δ = -120.6, -100.2 ppm; IR (neat) v~  = 669, 688, 745, 760, 785, 
835, 870, 992, 1054, 1101, 1159, 1281, 1321, 1406, 1464, 1515, 1583, 1620, 1697, 
1777, 2983, 3094 cm-1; ESI(pos.) [HDABCO]+ = 113 m/z; ESI(neg.) [DB(2,4,6-F-Ph)3]- = 
406 m/z; HRMS calcd. for C18H6DBF9: 406.056535; found: 406.056617. 
 
Stoichiometric reduction of diethyl benzylidenmalonate with [HDABCO][DB(2,4,6-
F-Ph)3]: 12.4 µl (0.055 mmol) of diethyl benzylidenmalonate were 
added to a stirring solution of [HDABCO][DB(2,4,6-F-Ph)3] (28.6 mg, 
0.055 mmol) in CD2Cl2. The resulting solution was heated to 50°C 
and followed by GC-MS. After 1 hour the reaction was completed. 
Then, the solvent was removed and the residue purified by column 
chromatography (SiO2, hexanes : ethyl acetate, 10:1) affording the D-labelled product . 
1H NMR (400 MHz, CDCl3) δ = 1.21 (t, J = 7.1 Hz, 3H9, 1.22 (t, J = 7.1 Hz, 3H), 3.20 (d, 
J = 7.8 Hz, 1H), 3.67 (d, J = 7.8 Hz, 1H), 4.12-4.20 (m, 4H), 7.19-7.22 (m, 3H), 7.26-7.30 
(m, 2H) ppm. 
13C NMR (100 MHz, CDCl3) δ = 14.1, 34.5 (t, J = 20.2 Hz), 53.9, 61.5, 126.8, 128.6, 
128.9, 134.0 ppm. 
IR (neat) v~  = 662, 699, 744, 786, 855, 909, 1033, 1095, 1148, 1175, 1207, 1256, 1368, 
1451, 1496, 1605, 1729, 2983 cm-1. 






















Selected NMR experiments 
 
1H NMR (300 MHz, CD2Cl2) 
 


























































































19F NMR (75 MHz, CD2Cl2) 
 


























11B NMR (96 MHz, CD2Cl2) 
 
















































13C NMR (75 MHz, CD2Cl2) 
 





































































































































































11B NMR (96 MHz, CD2Cl2) 
 

































































































11B NMR (96 MHz, CD2Cl2) 
 




























































































































































































































































































































13C NMR (101 MHz, CDCl3)  
 
 























































































































































13C NMR (75 MHz, CDCl3)  
 





















































































































































































































































































































































































































1H NMR (300 MHz, CDCl3)  
 























































































































Empirical formula  C20 H18 O4 S2 
Colour  colourless 
Formula weight  386.46  g · mol-1  
Temperature  100 K 
Wavelength  0.71073 Å 
Crystal system  MONOCLINIC 
Space group  p 21/c,  (no. 14)  
Unit cell dimensions a =   8.0772  (5) Å α= 90°. 
 b = 20.4379(12) Å β= 95.577(5)°. 
 c = 10.9593  (8) Å γ = 90°. 
Volume 1800.6(2) Å3 
Z 4 
Density (calculated) 1.426  Mg · m-3 
Absorption coefficient 0.319 mm-1 
F(000) 808 e 
Crystal size 0.47 x 0.11 x 0.08 mm3 
θ range for data collection 2.73 to 33.09°. 
Index ranges -12 ≤ h ≤ 12, -31≤ k ≤ 31, -16≤ l ≤ 16 
Reflections collected 37122 
Independent reflections 6831 [Rint = 0.0379] 
Reflections with I>2σ(I) 5533 
Completeness to θ = 27.50° 99.9 %  
Absorption correction Gaussian 
Max. and min. transmission 0.97556 and 0.90249 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6831 / 0 / 235 
Goodness-of-fit on F2 1.067 
Final R indices [I>2σ(I)] R1 = 0.0380 w R
2 = 0.0976 
R indices (all data) R1 = 0.0527 w R
2 = 0.1048 















    Proton ∆δ (ppm)a   
Relative 
Acidity (%) 
Lewis acid H1 H2 H3 H4  
3 -0,60 0,70 0,94 0,33 100 
4 -0,52 0,55 0,66 0,23 70 
5 -0,51 0,57 0,69 0,24 73 
7 -0,50 0,60 0,63 0,23 67 
6 -0,41 0,48 0,53 0,18 56 
a Chemical shifts were determined in CD2Cl2, (0.1 M). 
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